GemVax & KAEL Co Ltd
GemVax & KAEL Co Ltd designs and manufactures semiconductor components for the technology equipment industry.
Business. GemVax & KAEL Co Ltd (082270.KQ) is a technology equipment company operating in the semiconductors industry. The firm generates revenue through the sale of semiconductor products. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.
At a glance
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-06-25 · SE
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
GemVax & KAEL Co Ltd (082270.KQ) is a technology equipment company operating in the semiconductors industry. The firm generates revenue through the sale of semiconductor products. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data.
The company's capital structure shows a price-to-book ratio of 12.53 and a debt-to-equity ratio of 1.01, indicating a leveraged but not highly indebted position relative to equity. With cash and equivalents of 17,577.87 billion KRW and long-term debt of 58,070.71 billion KRW, the firm has negative net cash, which raises liquidity concerns. The current ratio of 0.66 suggests short-term liquidity is strained, as current liabilities exceed current assets.
Profitability metrics show significant underperformance relative to industry norms. The company reported a net loss of 11,336.64 billion KRW and an operating income of 2,471.24 billion KRW, resulting in a return on equity of -19.81% and return on assets of -7.14%. These figures are well below the typical performance of semiconductor firms, which usually maintain positive ROE and ROA in the 10-20% range.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of segment and geographic diversification increases exposure to sector-specific and regional risks.
Growth trajectory appears negative, with the company reporting a net loss in the latest period and free cash flow of -8,025.04 billion KRW. Analyst estimates for revenue and EPS also show a continuation of this trend, with last actual revenue at 65,663.22 billion KRW and EPS at -162.00 KRW. The outlook for the next fiscal year is not provided, but the current performance suggests a challenging path to growth.
Risk factors include medium liquidity risk due to the negative net cash position and a current ratio below 1. Dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. However, the company's negative net income and free cash flow could pressure the balance sheet and increase reliance on external financing in the future.
Recent financial filings show a deteriorating operating cash flow of 1,108.49 billion KRW and a capital expenditure of -997.19 billion KRW. No recent earnings call transcripts or major announcements are available in the provided data, but the financial snapshot indicates operational challenges that may require closer monitoring.
- The company is significantly underperforming in profitability with a negative ROE of -19.81% and ROA of -7.14%.
- Liquidity is strained with a current ratio of 0.66 and negative net cash position.
- Revenue is concentrated in a single business segment with no geographic diversification disclosed.
- Free cash flow is negative at -8,025.04 billion KRW, indicating operational cash generation challenges.
- The company's capital structure is leveraged with a debt-to-equity ratio of 1.01.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Forward curve
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- GemVax & KAEL Co Ltd Market data — financials · 2026-05-26
- GemVax & KAEL Co Ltd Market data — analyst estimates · 2026-05-26